Stockreport

FDA Removes Partial Clinical Hold on MacroGenics' LINNET Study [Yahoo! Finance]

MacroGenics, Inc.  (MGNX) 
Last macrogenics, inc. earnings: 11/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.macrogenics.com
PDF ROCKVILLE, MD, April 08, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody [Read more]